tiprankstipranks
Trending News
More News >
Diversified Healthcare Trust (DHC)
NASDAQ:DHC
Advertisement

Diversified Healthcare Trust (DHC) AI Stock Analysis

Compare
617 Followers

Top Page

DHC

Diversified Healthcare Trust

(NASDAQ:DHC)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
$4.50
▲(5.63% Upside)
The overall stock score of 54 reflects a mixed outlook. The company's financial performance is challenged by high leverage and profitability issues, but there is positive momentum in the stock's technical indicators. The earnings call provided some optimism with strategic initiatives, although labor costs and leverage remain concerns. The valuation is hindered by a negative P/E ratio, but the high dividend yield offers some appeal.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for healthcare real estate, supporting long-term business stability and expansion.
Successful Debt Refinancing
Refinancing improves financial flexibility and reduces near-term liquidity risks, allowing focus on strategic growth initiatives.
SHOP Occupancy Growth
Rising occupancy rates enhance revenue potential and reflect strong demand for senior living facilities, supporting stable cash flow.
Negative Factors
High Leverage
High leverage limits financial flexibility and increases risk, potentially impacting future investment and growth opportunities.
Elevated Labor Costs
Increased labor costs reduce profitability and may persist, affecting margins and operational efficiency in the long term.
Profitability Challenges
Ongoing profitability challenges hinder financial performance, requiring effective cost management to improve margins.

Diversified Healthcare Trust (DHC) vs. SPDR S&P 500 ETF (SPY)

Diversified Healthcare Trust Business Overview & Revenue Model

Company DescriptionDiversified Healthcare Trust (DHC) is a real estate investment trust (REIT) that focuses on acquiring, owning, and managing a diversified portfolio of healthcare properties. The company primarily invests in senior living communities and medical office buildings, catering to the growing demand for healthcare services and housing for the aging population. DHC aims to provide stable returns to its investors through its property management and leasing services, while maintaining a commitment to high-quality care and service in the healthcare sector.
How the Company Makes MoneyDHC generates revenue primarily through leasing its properties to healthcare operators and tenants, which include senior living facilities and medical office spaces. The company collects rent payments from these tenants, which serve as its main source of income. Additionally, DHC may earn revenue through property management fees and other ancillary services associated with its real estate assets. Partnerships with leading healthcare providers and operators enhance its ability to attract and retain tenants, thereby stabilizing its cash flow. Moreover, the demand for healthcare real estate, driven by demographic trends such as an aging population, contributes to DHC's revenue potential.

Diversified Healthcare Trust Earnings Call Summary

Earnings Call Date:Nov 03, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 03, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted positive revenue growth, successful refinancing, and strategic asset sales. However, it was tempered by challenges such as elevated labor costs and high leverage. Despite these challenges, the company remains optimistic about future performance and strategic initiatives.
Q3-2025 Updates
Positive Updates
Increased Total Revenue
Total revenue for the quarter was $388.7 million, an increase of 4% year-over-year.
SHOP Occupancy Growth
SHOP occupancy increased 210 basis points year-over-year to 81.5%, marking the fourth consecutive quarter of occupancy growth.
Successful Debt Refinancing
Completed a $1 billion refinancing of the Vertex Pharmaceuticals' headquarters and issued $375 million of senior secured notes, leading to no debt maturities until 2028.
Medical Office and Life Science Leasing Success
Completed approximately 86,000 square feet of leasing at weighted average rents of 9% above prior rents with an average term of nearly 7 years.
Asset Sale Proceeds
Year-to-date, sold 44 properties for $396 million, with additional agreements to sell 38 properties for $237 million.
Negative Updates
Elevated Labor Costs
NOI temporarily declined due to elevated labor costs associated with the transition of AlerisLife communities, adding an incremental cost of $5.1 million for the quarter.
Sequential Decline in SHOP NOI
Sequential decline in SHOP NOI mainly due to higher seasonal utility costs and temporary labor costs related to community transitions.
High Leverage
Net debt-to-adjusted EBITDAre was 10x, primarily reflecting temporary compensation expense increases.
Company Guidance
During the Diversified Healthcare Trust (DHC) Third Quarter 2025 Earnings Conference Call, management provided guidance reflecting continued progress despite temporary challenges. Total revenue for the quarter was $388.7 million, marking a 4% year-over-year increase, while adjusted EBITDAre was $62.9 million and normalized FFO was $9.7 million or $0.04 per share. The company is transitioning 116 AlerisLife-managed communities to new operators, which contributed to a temporary decline in net operating income (NOI) due to elevated labor costs, with compensation expenses around 240 basis points above the portfolio average, translating to an additional $5.1 million for the quarter. DHC maintained its full-year SHOP NOI guidance range of $132 million to $142 million and reported a 210 basis point year-over-year increase in SHOP occupancy to 81.5%. The Medical Office and Life Science portfolio saw a 370 basis point sequential increase in consolidated occupancy to 86.6%, alongside a 1.6% year-over-year rise in same-property cash basis NOI. The company anticipates improved liquidity and expects to repay its January 2026 bonds by year-end, with no debt maturities until 2028, reflecting a strong financial position moving forward.

Diversified Healthcare Trust Financial Statement Overview

Summary
Diversified Healthcare Trust shows revenue growth but struggles with profitability and high leverage. Improved cash flow is a positive, but high debt and negative returns on equity are concerns.
Income Statement
45
Neutral
The income statement shows a mixed performance. While there is a positive revenue growth trend, the company is struggling with negative net and EBIT margins, indicating profitability issues. The gross profit margin has improved significantly in the TTM period, but the net profit margin remains negative, suggesting ongoing challenges in cost management and operational efficiency.
Balance Sheet
50
Neutral
The balance sheet reflects a high debt-to-equity ratio, which poses a risk of financial leverage. The return on equity is negative, indicating that the company is not generating sufficient returns on shareholders' investments. However, the equity ratio is relatively stable, suggesting a balanced asset structure.
Cash Flow
55
Neutral
The cash flow statement shows improvement in free cash flow growth, indicating better cash management. The operating cash flow to net income ratio is positive, suggesting that the company is generating cash from its operations despite net losses. However, the high free cash flow to net income ratio indicates reliance on non-operational cash sources.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.54B1.50B1.41B1.28B1.38B1.63B
Gross Profit206.75M256.38M225.30M171.89M273.89M394.86M
EBITDA88.06M229.96M198.93M145.70M232.60M356.86M
Net Income-352.11M-370.25M-293.57M-15.77M174.51M-139.45M
Balance Sheet
Total Assets4.68B5.14B5.45B6.00B6.62B6.48B
Cash, Cash Equivalents and Short-Term Investments201.37M144.58M245.94M658.07M634.85M74.42M
Total Debt0.002.91B2.82B3.05B3.68B3.57B
Total Liabilities3.00B3.18B3.11B3.36B3.96B3.86B
Stockholders Equity1.69B1.96B2.34B2.64B2.66B2.62B
Cash Flow
Free Cash Flow33.79M112.22M10.48M-339.74M-290.93M-27.04M
Operating Cash Flow67.97M112.22M10.48M-40.35M-63.32M158.54M
Investing Cash Flow203.90M-187.02M-202.11M387.71M242.70M-40.44M
Financing Cash Flow-384.69M-22.31M-249.71M-676.00M746.72M-79.48M

Diversified Healthcare Trust Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4.26
Price Trends
50DMA
4.23
Positive
100DMA
3.89
Positive
200DMA
3.26
Positive
Market Momentum
MACD
0.02
Negative
RSI
52.43
Neutral
STOCH
73.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DHC, the sentiment is Positive. The current price of 4.26 is above the 20-day moving average (MA) of 4.18, above the 50-day MA of 4.23, and above the 200-day MA of 3.26, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 52.43 is Neutral, neither overbought nor oversold. The STOCH value of 73.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DHC.

Diversified Healthcare Trust Risk Analysis

Diversified Healthcare Trust disclosed 59 risk factors in its most recent earnings report. Diversified Healthcare Trust reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Diversified Healthcare Trust Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$12.70B24.1511.28%6.23%13.50%31.56%
74
Outperform
$1.64B19.513.49%6.41%11.89%-68.41%
69
Neutral
$1.31B33.372.78%6.76%3.74%78.09%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
60
Neutral
$581.52M89.600.49%11.94%0.57%-131.16%
54
Neutral
$1.02B-18.84%0.94%4.10%8.96%
54
Neutral
$2.96B-14.02%6.57%45.56%73.44%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DHC
Diversified Healthcare Trust
4.26
1.42
50.14%
LTC
LTC Properties
35.58
<0.01
0.03%
OHI
Omega Healthcare
43.02
6.07
16.43%
MPW
Medical Properties
4.87
0.59
13.79%
GMRE
Global Medical REIT
31.80
-10.14
-24.18%
SILA
Sila Realty Trust, Inc.
23.48
0.70
3.07%

Diversified Healthcare Trust Corporate Events

Business Operations and StrategyFinancial Disclosures
Diversified Healthcare Trust Unveils Strategic Initiatives
Positive
Oct 8, 2025

On October 8, 2025, Diversified Healthcare Trust released an investor presentation highlighting its strategic initiatives and financial outlook. The company is focusing on improving its senior housing operating portfolio through various strategic initiatives, including operator transitions and occupancy growth. DHC is also engaging in capital recycling plans and expects favorable trends in the senior living and medical office sectors to support its growth. The presentation also outlined the company’s second-quarter results and 2025 guidance, showing improvements in SHOP margin and occupancy rates.

The most recent analyst rating on (DHC) stock is a Buy with a $5.50 price target. To see the full list of analyst forecasts on Diversified Healthcare Trust stock, see the DHC Stock Forecast page.

Private Placements and Financing
Diversified Healthcare Trust Completes $375M Note Offering
Neutral
Sep 29, 2025

On September 26, 2025, Diversified Healthcare Trust completed a private offering of $375 million in senior secured notes due 2030, with net proceeds of approximately $365.9 million. The company used part of these proceeds to partially redeem its 2026 senior secured notes, with the remaining funds intended for fees, expenses, and general business purposes. The notes are guaranteed by subsidiaries owning 36 properties in the U.S. and are subject to restrictive covenants.

The most recent analyst rating on (DHC) stock is a Buy with a $5.50 price target. To see the full list of analyst forecasts on Diversified Healthcare Trust stock, see the DHC Stock Forecast page.

Business Operations and StrategyM&A Transactions
Diversified Healthcare Trust Sells Senior Living Management
Positive
Sep 3, 2025

On September 3, 2025, Diversified Healthcare Trust announced the sale of management agreements for 116 senior living communities to seven different operators, as part of AlerisLife Inc.’s asset sale and business wind-down. This strategic move is expected to impact DHC’s operations by aligning with its capital recycling plans and enhancing its focus on core assets, potentially benefiting stakeholders through improved financial stability and positioning within the healthcare real estate market.

The most recent analyst rating on (DHC) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Diversified Healthcare Trust stock, see the DHC Stock Forecast page.

Diversified Healthcare Trust’s Optimistic Earnings Call Highlights
Aug 7, 2025

The recent earnings call of Diversified Healthcare Trust painted a largely optimistic picture, highlighting strong financial results and strategic initiatives poised for future growth. The company reported increased revenue, EBITDA, and FFO, alongside successful leasing activities and improved performance in its SHOP segment. However, challenges such as occupancy issues and anticipated expense increases were also noted, tempering the overall positive sentiment with a dose of caution.

Diversified Healthcare Trust Reports Q2 2025 Results
Aug 6, 2025

Diversified Healthcare Trust (DHC) is a real estate investment trust specializing in high-quality healthcare properties across the United States, with a diversified portfolio that includes senior living units, medical offices, and life science properties.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 04, 2025